James P. Allison and Tasuku Honjo won the 2018 Nobel Prize in Physiology or Medicine for their successful development of inhibitors of CTLA4 and PD‐1 to treat a variety of intractable cancers. This evidence concerns the gene CTLA4 and cancer.